ACCUTEST

Accutest Research Laboratories

@accutest_research

Navi Mumbai, Maharashtra
https://www.accutestglobal.com/
Research Services

Overview

About Accutest Research Laboratories

Accutest Research Laboratories Pvt. Ltd., is an Indian, independent clinical research organization (CRO) that has been at the forefront of comprehensive drug development and testing services since its inception in 1998. Our commitment to excellence and unwavering dedication to quality have positioned us as a trusted partner for pharmaceutical companies looking for reliable partner for their Bioequivalence, clinical development services in India and across the globe.

Capabilities:

Clinical Facilities: 262 beds across Navi Mumbai and Vadodara.
Bio-analytics: Two facilities in Navi Mumbai.
Biologics: Dedicated lab in Navi Mumbai.
Accutest's facilities are accredited by regulatory bodies like DCGI, US FDA, ANVISA, EMA, WHO, NPRA, and OECD-GLP.

Key Services:

BA/BE Studies: Specializes in complex generics and biosimilars with 131+ regulatory audits.
Clinical Development: Phase II-IV studies, PMS, and nutraceuticals.
Biologics Services: Characterization, comparability studies, and immunogenicity assessments.
Statistical Services: PK/PD studies, clinical endpoint studies, and protocol development.

Value Proposition:

Regulatory Excellence: 131+ successful inspections.
Proven History: Extensive regulatory experience and numerous submissions.
Expert Team: Highly qualified staff with over 100+ years of experience.
Cutting-Edge Facilities: Advanced labs and clinics with a large volunteer pool.
Data Security: GAMP®5 certified professionals and advanced IT systems.
Robust Controls: Efficient project tracking and monitoring systems.
Dedicated Project Management: Ensures timely execution and feedback.

Accutest fosters collaboration, innovation, and impact in BA/BE, clinical development, and biologics.

Headquarters

Navi Mumbai, Maharashtra

Company Size

501-1,000 employees

Industry

Research Services

Company Type

Privately Held

Founded

1998

Specialties

clinical research, BA/BE, Bioequivalence, clinical development services, Biologics, Biosimilars , Bioavailability, Phase II to IV studies, biologics characterization, clinical comparability, immunogenicity assessments , Statistical Services, and GAMP®5